Beta Drugs Limited — Others, 12-03-2025: Amendment to AOA/MOA

Beta Drugs Limited has announced a board meeting to discuss the alteration of its Memorandum of Association, specifically updating the capital clause due to an increase in authorized share capital from ₹10.5 crore to ₹11 crore. This change, approved by shareholders through remote e-voting, allows for an additional issuance of equity shares, enhancing the company’s flexibility for future financing and growth opportunities.

Investors may view this development favorably as it positions the company for potential expansion, although it also introduces considerations regarding dilution of existing shares. Overall, this update signals a proactive approach to capital management.